← back to search

Yoshiki Hirooka

Itochu (Japan) · JP
Area of research
Surgery · Pulmonary and Respiratory Medicine
Research interest
Research interests include Pancreatic and Hepatic Oncology Research, Pancreatitis Pathology and Treatment, Gastric Cancer Management and Outcomes, and Gallbladder and Bile Duct Disorders.
h-index
60
citations
13,982
works
821
NIH funding
primary concept
Medicine
email

Recent publications

The Central Role of Liver Function at Treatment Initiation and Its Preservation at Progression for Post-Progression Survival After Atezolizumab Plus Bevacizumab in Advanced Hepatocellular Carcinoma.
2026cited by 0position: contributordoi
Agaro-Oligosaccharide Supplementation Alters the Gut Microbiota, Revealing Potential Agaro-Oligosaccharide-Utilizing Taxa in Healthy Japanese Adults
Biomedicines 2026cited by 0position: contributordoi
Current status of endoscopic ultrasound in the diagnosis of intraductal papillary mucinous neoplasms.
2025cited by 7position: contributordoi
Host Dietary Nutrients Shape GH32-Mediated Microbial Responses to Prebiotic Fructans: A Randomized Trial.
2025cited by 1position: contributordoi
Biomarker-Based Responder Selection and Early Prediction of Treatment Response in Hepatocellular Carcinoma: Dynamic Changes in Alpha-Fetoprotein and Des-Gamma-Carboxy Prothrombin During Atezolizumab Plus Bevacizumab Therapy.
2025cited by 1position: contributordoi
Modulation of the Gut Microbiota by <i>Nopalea cochenillifera</i> (Prickly Pear Cactus) Contributes to Improved Lipid Metabolism and Immune Function.
2025cited by 0position: contributordoi
Contrast-enhanced ultrasound imaging characteristics of intrahepatic cholangiocarcinoma with actionable gene variants detected by comprehensive cancer gene panel testing.
2025cited by 0position: contributordoi
Efficacy of 1-Kestose Supplementation in Patients with Pancreatic Ductal Adenocarcinoma: A Randomized Controlled Pilot Study.
2024cited by 8position: contributordoi
Impaired Fat Absorption from Intestinal Tract in High-Fat Diet Fed Male Mice Deficient in Proglucagon-Derived Peptides.
2024cited by 7position: contributordoi
Characteristics and Prognosis of Patients with Advanced Hepatocellular Carcinoma Treated with Atezolizumab/Bevacizumab Combination Therapy Who Achieved Complete Response.
2024cited by 5position: contributordoi
Early Changes in Alpha-Fetoprotein and Des-γ-Carboxy Prothrombin Are Useful Predictors of Antitumor Response to Durvalumab Plus Tremelimumab Therapy for Advanced Hepatocellular Carcinoma.
2024cited by 4position: contributordoi
Early Changes in Alpha-Fetoprotein and Des-γ-Carboxy Prothrombin Are Useful Predictors of Antitumor Response to Durvalumab Plus Tremelimumab Therapy for Advanced Hepatocellular Carcinoma
2024cited by 0position: contributordoi
Protocol for a Multi-Center Confirmatory Trial to Evaluate the Differential Diagnostic Performance of Contrast-Enhanced Ultrasonography Using Perflubutane in Patients with a Pancreatic Mass: A Multicenter Prospective Study.
2024cited by 0position: contributordoi
Erdafitinib in patients with advanced solid tumours with FGFR alterations (RAGNAR): an international, single-arm, phase 2 study
The Lancet Oncology 2023cited by 191position: middledoi
Current Status of the Diagnosis of Early-Stage Pancreatic Ductal Adenocarcinoma.
2023cited by 28position: contributordoi
Injury to the muscle layer, increasing the risk of post-colorectal endoscopic submucosal dissection electrocoagulation syndrome.
2023cited by 14position: contributordoi
Clinical Outcomes of Cabozantinib in Patients Previously Treated with Atezolizumab/Bevacizumab for Advanced Hepatocellular Carcinoma-Importance of Good Liver Function and Good Performance Status.
2023cited by 9position: contributordoi
Scoring system for predicting the prognosis of elderly gastric cancer patients after endoscopic submucosal dissection.
2023cited by 5position: contributordoi
A rare case of inflammatory polyp in the common bile duct with cholangitis.
2023cited by 2position: contributordoi
Incidence and clinical relevance of postoperative diarrhea after minimally invasive gastrectomy for gastric cancer: a single institution retrospective study of 1476 patients.
2023cited by 1position: contributordoi
Usefulness of Macroscopic On-Site Evaluation Using a Stereomicroscope during EUS-FNB for Diagnosing Solid Pancreatic Lesions.
2022cited by 11position: contributordoi
Current status of the diagnosis of chronic pancreatitis by ultrasonographic elastography.
2022cited by 7position: contributordoi
Examination of Abnormal Alpha-synuclein Aggregates in the Enteric Neural Plexus in Patients with Ulcerative Colitis.
2022cited by 5position: contributordoi
A rare case of pancreatic neuroendocrine neoplasm causing Cushing's syndrome.
2022cited by 3position: contributordoi
Detection and Characterization of Gastric Cancer Using Cascade Deep Learning Model in Endoscopic Images.
2022cited by 3position: contributordoi
Novel image enhancement technology that helps find bleeding points during endoscopic submucosal dissection of gastric neoplasms.
2022cited by 2position: contributordoi
The Effects of Enteral Nutrition on the Intestinal Environment in Patients in a Persistent Vegetative State.
2022cited by 2position: contributordoi
MicroRNA Profile of Human Small Intestinal Tumors Compared to Colorectal Tumors.
2022cited by 1position: contributordoi
Transabdominal ultrasonographic diagnosis of relatively rare pancreatic neoplasms.
2022cited by 0position: contributordoi
A Case of Extramedullary Plasmacytoma of the Biliary Tract with a Poor Prognosis.
2022cited by 0position: contributordoi

Grants

No grants ingested yet.

Frequent collaborators

· 39 papers (2019–2026)Kohei Funasaka · Fujita Health University11 papers (2021–2026)Teiji Kuzuya · Fujita Health University10 papers (2021–2026)Kazunori Nakaoka · Fujita Health University10 papers (2021–2026)Hiroki Kawashima · Kanazawa Medical University8 papers (2019–2023)Senju Hashimoto · Springer Nature6 papers (2021–2024)Takuya Ishikawa · Nagoya University4 papers (2019–2023)Masanao Nakamura · Nagoya University4 papers (2019–2023)Eizaburo Ohno · Elsevier, Inc.4 papers (2021–2025)Mitsuhiro Fujishiro · The Institute of Medical Science, Asahi Life Foundation3 papers (2019–2023)Ryoji Miyahara · Springer Nature3 papers (2022–2023)Koichi Suda · Fujita Health University3 papers (2022–2023) · 2 papers (2021–2022)Atsushi Masamune · Jichi Medical University2 papers (2021–2024)Atsushi Teramoto · Meijo University2 papers (2021–2022)Ayako Watanabe · Fujita Health University2 papers (2022–2023) · 2 papers (2022–2023) · 2 papers (2021–2023) · 2 papers (2021–2022)Naoto Kawabe · Fujita Health University2 papers (2021–2024)